These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11083537)

  • 1. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
    Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
    Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
    Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A
    Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
    Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
    Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
    Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
    Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases.
    Vishne TH; Ron IG
    Am J Clin Oncol; 1998 Dec; 21(6):602-4. PubMed ID: 9856663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
    Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
    Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
    Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
    Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone.
    McEwan AJ; Amyotte GA; McGowan DG; MacGillivray JA; Porter AT
    Eur Urol; 1994; 26 Suppl 1():26-31. PubMed ID: 7537666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to bone.
    Porter AT
    Eur Urol; 1994; 26 Suppl 1():20-5. PubMed ID: 7537665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of systemic radiotherapy with high-purity 89Sr chloride in the treatment of bone metastases].
    Fomin DK; Tararukhina OB; Nazarov AA
    Vestn Rentgenol Radiol; 2012; (2):29-31. PubMed ID: 22730757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone metastases treated with radiopharmaceuticals].
    Giammarile F
    Bull Cancer; 2013 Nov; 100(11):1223-7. PubMed ID: 24409472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [89Sr Therapy for pain relief in patients with bone metastases].
    Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
    Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases.
    Kasalický J; Krajská V
    Eur J Nucl Med; 1998 Oct; 25(10):1362-7. PubMed ID: 9818274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
    Ouyang W; Liu JH; Liu WY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of systemic radiotherapy in the combined treatment for hormone-resistant prostate cancer].
    Solodky VA; Pavlov AY; Panshin GA; Gafanov RA; Fastovets SV; Isaev TK
    Vopr Onkol; 2015; 61(1):31-3. PubMed ID: 26016142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
    Bauman G; Charette M; Reid R; Sathya J
    Radiother Oncol; 2005 Jun; 75(3):258-70. PubMed ID: 16299924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.